Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-07 · accession 0001415889-24-021057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-09 | 2024-08-07 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $7.83 | +3,252 | 1.84M | +0.2% | +$25.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-08-07 | A | A | 3,252 | $7.83 | 1,839,896 | D | — | — |